Neuphoria Therapeutics (NEUP) EBIAT (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported EBIAT of -$500000.0 for Q1 2026, down 104.44% year-over-year from $11.3 million in Q1 2025, and down 126.82% quarter-over-quarter from $1.9 million in Q4 2025.
Neuphoria Therapeutics (NEUP) EBIAT (2023 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has 4 years of EBIAT data on file, last reported at -$500000.0 in Q1 2026.
- EBIAT for Q1 2026 came in at -$500000.0, down 104.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.4 million (down 399.74% YoY), and the FY2025 annual result was -$400000.0, up 97.42% from the prior year.
- EBIAT eased to -$500000.0 in Q1 2026 per NEUP's latest filing, from $1.9 million in the prior quarter.
- Over five years, EBIAT peaked at $11.3 million in Q1 2025 and troughed at -$9.9 million in Q3 2025.
- A 4-year average of -$2.2 million and a median of -$2.7 million in 2024 frame the typical range for EBIAT.
- On a YoY basis, EBIAT climbed as much as 505.38% in 2025 and fell as far as 1130.95% in 2025.
- A 4-year view of EBIAT shows it stood at -$4.6 million in 2023, then surged by 57.33% to -$1.9 million in 2024, then soared by 195.92% to $1.9 million in 2025, then tumbled by 126.82% to -$500000.0 in 2026.
- Business Quant data shows NEUP's EBIAT at -$500000.0 in Q1 2026, $1.9 million in Q4 2025, and -$9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Neuphoria Therapeutics | 23.86 Mn | 4.46 Mn | - | -500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | -9.91 Mn |
| Jun 30, 2025 | -8.90 Mn |
| Mar 31, 2025 | 11.26 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | -804,787.00 |
| Jun 30, 2024 | -2.69 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -4.55 Mn |
| Sep 30, 2023 | -5.47 Mn |